Biotechnology and Bioprocess Engineering

, Volume 23, Issue 5, pp 588–597 | Cite as

3D Astrogliosis Model with bFGF and GFAP Expression Profiles Corresponding to an MCAO-injured Brain

  • Seul Ki Min
  • Hyeon Jung Shim
  • Hwa Sung ShinEmail author
Research Paper


Various brain diseases including ischemic stroke cause profound changes in the cells of the brain. In order to develop neuroprotective drugs useful in overcoming brain diseases, pathologic cellular changes such as astrogliosis in lesion sites have to be better understood. Many drug development trials, which are often unsuccessful, require the sacrifice of large numbers of animals, leading to ethical issues and enormous expenditures of time and financial resources. Therefore, initial screening should be performed using in vitro models that are similar to the in vivo context in order to mitigate these concerns as much as possible. In this study, we developed an astrocyte culture model employing a three-dimensional (3D) nanofibrous mat that may be able to replace vast numbers of animal experiments in studies of middle cerebral artery occlusion (MCAO), ischemic stroke and reperfusion, and related brain damage. To induce artificial activation of astrocytes, 3D cultures were exogenously treated with TGF-β1. Subsequent changes in astrocytes were monitored and characterized by using qRT-PCR, western blot, and confocal microscopy of immunocytochemically stained cells. We observed that, upon treatment with TGF-β1, bFGF was upregulated and accompanied a change in GFAP expression in 3D astrocyte cultures, similar to that observed in MCAO-injured brain tissue. These changes were demonstrated to be associated with bFGF signaling through the application of 5′-Deoxy- 5′-(methylthio)adenosine treatment. We conclude that astrocytes cultured with TGF-β1 in our 3D nanofiber culture model mimics in vivo-like bFGF signaling and could be used as an in vitro model system to study astrogliosis after MCAO and reperfusion.


3D nanofiber culture model MCAO astrogliosis TGF-β1 bFGF GFAP 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Supplementary material

12257_2018_207_MOESM1_ESM.pdf (188 kb)
3D Astrogliosis Model with bFGF and GFAP Expression Profiles Corresponding to an MCAO-injured Brain


  1. 1.
    Colangelo, A. M., L. Alberghina, and M. Papa (2014) Astrogliosis as a therapeutic target for neurodegenerative diseases. Neurosci. Lett. 565: 59–64.CrossRefGoogle Scholar
  2. 2.
    Koyama, Y. (2015) Functional alterations of astrocytes in mental disorders: pharmacological significance as a drug target. Front. Cell. Neurosci. 9: 261.CrossRefGoogle Scholar
  3. 3.
    Fernández-Moriano, C., P. K. Divakar, A. Crespo, and M. P. Gómez-Serranillos (2015) Neuroprotective activity and cytotoxic potential of two Parmeliaceae lichens: Identification of active compounds. Phytomedicine 22: 847–855.CrossRefGoogle Scholar
  4. 4.
    Yazdi, H. K., M. Fazilati, R. Rahbarian, G. Riazi, and H. Nazem (2017) Aqueous extract of Launaea acanthodes induces glutamate uptake and GABA release in astrocyte cell culture via a ROS scavenging mediated process. J. Chem. Neuroanat. 82: 1–4.CrossRefGoogle Scholar
  5. 5.
    Goldshmit, Y., F. Frisca, A. R. Pinto, A. Pébay, J. K. Y. Tang, A. L. Siegel, J. Kaslin, and P. D. Currie (2014) Fgf2 improves functional recovery-decreasing gliosis and increasing radial glia and neural progenitor cells after spinal cord injury. Brain Behav. 4: 187–200.CrossRefGoogle Scholar
  6. 6.
    Ay, H., I. Ay, W. Koroshetz, and S. Finklestein (1999) Potential usefulness of basic fibroblast growth factor as a treatment for stroke. Cerebrovasc. Dis. 9: 131–135.CrossRefGoogle Scholar
  7. 7.
    Yu, P., H. Wang, Y. Katagiri, and H. M. Geller (2012) An in vitro model of reactive astrogliosis and its effect on neuronal growth. Astrocytes: Methods Protocols 327–340.Google Scholar
  8. 8.
    East, E., J. P. Golding, and J. B. Phillips (2009) A versatile 3D culture model facilitates monitoring of astrocytes undergoing reactive gliosis. J. Tissue Eng. Regen. M 3: 634–646.CrossRefGoogle Scholar
  9. 9.
    Brahmachari, S., Y. K. Fung, and K. Pahan (2006) Induction of glial fibrillary acidic protein expression in astrocytes by nitric oxide. J. Neurosci. 26: 4930–4939.CrossRefGoogle Scholar
  10. 10.
    Rocha, D. N., J. P. Ferraz-Nogueira, C. C. Barrias, J. B. Relvas, and A. P. Pêgo (2015) Extracellular environment contribution to astrogliosis-lessons learned from a tissue engineered 3D model of the glial scar. Front. Cell. Neurosci. 9: 377.CrossRefGoogle Scholar
  11. 11.
    Bederson, J. B., L. H. Pitts, M. Tsuji, M. C. Nishimura, R. L. Davis, and H. Bartkowski (1986) Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 17: 472–476.CrossRefGoogle Scholar
  12. 12.
    Zhang, H. Y., X. Zhang, Z. G. Wang, H. X. Shi, F. Z. Wu, B. B. Lin, X. L. Xu, X. J. Wang, X. B. Fu, Z. Y. Li, C. J. Shen, X. K. Li, and J. Xiao (2013) Exogenous basic fibroblast growth factor inhibits ER stress-induced apoptosis and improves recovery from spinal cord injury. CNS Neurosci. Ther. 19: 20–29.CrossRefGoogle Scholar
  13. 13.
    Lindholm, D., E. Castren, R. Kiefer, F. Zafra, and H. Thoenen (1992) Transforming growth factor-beta 1 in the rat brain: increase after injury and inhibition of astrocyte proliferation. J. Cell Biol. 117: 395–400.CrossRefGoogle Scholar
  14. 14.
    Reilly, J. F., P. A. Maher, and V. G. Kumari (1998) Regulation of astrocyte GFAP expreßsion by TGF-ß1 and FGF-2. Glia 22: 202–210.CrossRefGoogle Scholar
  15. 15.
    Min, S. K., S. H. Kim, C. R. Kim, S. M. Paik, S. M. Jung, and H. S. Shin (2013) Effect of topography of an electrospun nanofiber on modulation of activity of primary rat astrocytes. Neurosci. Lett. 534: 80–84.CrossRefGoogle Scholar
  16. 16.
    Min, S. K., C. R. Kim, S. M. Jung, and H. S. Shin (2013) Astrocyte behavior and GFAP expression on Spirulina extractincorporated PCL nanofiber. J. Biomed. Mater. Res. A 101: 3467–3473.CrossRefGoogle Scholar
  17. 17.
    Gomez-Pinilla, F., L. Vu, and C. W. Cotman (1995) Regulation of astrocyte proliferation by FGF-2 and heparan sulfate in vivo. J. Neurosci. 15: 2021–2029.CrossRefGoogle Scholar
  18. 18.
    Zhang, D., X. Hu, L. Qian, J. P. O’Callaghan, and J. S. Hong (2010) Astrogliosis in CNS pathologies: is there a role for microglia Mol. Neurobiol. 41: 232–241.Google Scholar
  19. 19.
    Hanisch, U. K. (2002) Microglia as a source and target of cytokines. Glia 40: 140–155.CrossRefGoogle Scholar
  20. 20.
    Yu, P., H. Wang, Y. Katagiri, and H. M. Geller (2012) An in vitro model of reactive astrogliosis and its effect on neuronal growth. Astrocytes: Methods Protocols 327–340.Google Scholar
  21. 21.
    Rotschafer, J. H., S. Hu, M. Little, M. Erickson, W. C. Low, and M. C. Cheeran (2013) Modulation of neural stem/progenitor cell proliferation during experimental Herpes Simplex encephalitis is mediated by differential FGF-2 expression in the adult brain. Neurobiol. Dis. 58: 144–155.CrossRefGoogle Scholar
  22. 22.
    Gómez-Pinilla, F., B. J. Cummings, and C. W. Cotman (1990) Induction of basic fibroblast growth factor in Alzheimer’s disease pathology. Neuroreport 1: 211–214.CrossRefGoogle Scholar
  23. 23.
    Madiai, F., S. R. A. Hussain, V. M. Goettl, R. W. Burry, R. L. Stephens, and K. V. Hackshaw (2003) Upregulation of FGF-2 in reactive spinal cord astrocytes following unilateral lumbar spinal nerve ligation. Exp. Brain Res. 148: 366–376.CrossRefGoogle Scholar
  24. 24.
    Choudhury, G. R. and S. Ding (2016) Reactive astrocytes and therapeutic potential in focal ischemic stroke. Neurobiol. Dis. 85: 234–244.CrossRefGoogle Scholar
  25. 25.
    Hou, Y. J., A. C. H. Yu, J. M. R. Z. Garcia, A. Aotaki-Keen, Y. L. Lee, L.F. Eng, L. J. Hjelmeland, and V. K. Menon (1995) Astrogliosis in culture. IV. Effects of basic fibroblast growth factor. J. Neurosci. Res. 40: 359–370.CrossRefGoogle Scholar
  26. 26.
    Petroski, R. E., J. P. Grierson, S. Choi-Kwon, and H. M. Geller (1991) Basic fibroblast growth factor regulates the ability of astrocytes to support hypothalamic neuronal survival in vitro. Dev. Bio. 147: 1–13.CrossRefGoogle Scholar
  27. 27.
    Lin, G. and J. E. Goldman (2009) An FGF-responsive astrocyte precursor isolated from the neonatal forebrain. Glia 57: 592–603.CrossRefGoogle Scholar
  28. 28.
    Soulere, R. C. P., J. A. Casademunt, R. Sunyer, J. S. Martí, R. F. Ventura, and D. N. Navarro (2008) Micropatterning of single endothelial cell shape reveals a tight coupling between nuclear volume in G1 and proliferation. Biophys. J. 94: 4984–4995.CrossRefGoogle Scholar
  29. 29.
    Joy, A., J. Moffet, K. Neary, E. Mordechai, E. K. Stachowiak, S. Coons, J. Rankin-Shapiro, R. Z. Florkiewicz, and M. K. Stachowiak (1997) Nuclear accumulation of FGF-2 is associated with proliferation of human astrocytes and glioma cells. Oncogene 14: 171–183.CrossRefGoogle Scholar
  30. 30.
    Stukel, J. M. and R.K. Willits (2016) Mechanotransduction of neural cells through cell-substrate interactions. Tissue Eng. Part B Rev. 22: 173–182.CrossRefGoogle Scholar
  31. 31.
    Yu, R. K., Y. T. Tsai, T. Ariga, and M. Yanaqisawa (2011) Structures, biosynthesis, and functions of gangliosides-an overview. J. Oleo. Sci. 60: 534–537.CrossRefGoogle Scholar

Copyright information

© The Korean Society for Biotechnology and Bioengineering and Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  • Seul Ki Min
    • 1
  • Hyeon Jung Shim
    • 1
  • Hwa Sung Shin
    • 1
    Email author
  1. 1.Department of Biological EngineeringInha UniversityIncheonKorea

Personalised recommendations